Updated:
Cellular Biomedicine Group, Inc.
Cellular Biomedicine Group, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001378624, and its reported...
Overview
Cellular Biomedicine Group, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001378624, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2020-02-28, it reported annual revenue of USD 339,920; net income of USD -49,984,054; total assets of USD 97,324,300 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Cellular Biomedicine Group, Inc.
- Former names in filing history
- EastBridge Investment Group Corp (2006-10-31 to 2013-02-22)
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Rockville, MD, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001378624
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2019USD | $339,920 | -$50.0M | $97.3M | $15.4M | -$39.6M | |
| FY2018USD | $224,403 | -$38.9M | $91.6M | — | -$25.1M | |
| FY2017USD | $336,817 | -$25.5M | $61.2M | — | -$18.6M | |
| FY2016USD | $627,930 | -$28.2M | $68.6M | — | -$15.9M |
FY2019. Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
FY2018. Total assets: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | CURRENT REPORT | ||
| 8-K | FORM 8-K | ||
| DEF 14A | PRIMARY DOCUMENT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | 8-K | ||
| 8-K | CURRENT REPORT | ||
| 10-Q | QUARTERLY REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | PRIMARY DOCUMENT | ||
| SC 13D | — | SC 13D | |
| 10-Q | QUARTERLY REPORT | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Cellular Biomedicine Group, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.